news

UK firms move from AI experimentation to measurable results as the Project Economy matures

Nearly half of UK organisations report productivity or cost improvements from AI, with a growing cohort (12%) already achieving significant…

3 weeks ago

Hannover Messe 2026: Zoomlion Debuts Robot Ops, Showcasing Industrial AI and Intelligent Manufacturing Capabilities

HANNOVER, Germany, April 22, 2026 /PRNewswire/ -- Zoomlion Heavy Industry Science & Technology Co., Ltd. ("Zoomlion" or "the Company"; 1157.HK)…

3 weeks ago

QC Ware Announces 5th Q2B Tokyo Conference Focused on the Roadmap to Quantum Value in Asia and Beyond, Quemix to Co-host and Sponsor

QC Ware hosts the 5th Q2B conference in Tokyo to connect the Asian and global quantum technology landscape and bring together…

3 weeks ago

MetaComp launches the world’s first AI agent governance framework for regulated financial services

Introduced at Money20/20 Asia, the StableX Know Your Agent Framework establishes how AI agents are identified, authorised, monitored and held…

3 weeks ago

TV Rheinland Opens Advanced Automotive Component Testing Laboratory in Manesar, Haryana

Empowering automotive industry capabilities through precision testing, international compliance, and innovative solutions for next-generation mobility.MANESAR, India, April 22, 2026 /PRNewswire/…

3 weeks ago

Changan Group Advances Global Strategy with “1+4+4+5” Framework, Targeting RMB 600 Billion in Revenue by 2030

CHONGQING, China, April 21, 2026 /PRNewswire/ -- The Group sets out Six Major Leaps and five doubling targets, with RMB 600…

3 weeks ago

HarperCollins is proud to announce the forthcoming publication of A Beginner’s Guide to the Indian Stock Market by Karthik Rangappa

Paperback | Non-Fiction | 228 pp | INR 499; Pre-Order now | Releasing 24th April 2026NEW DELHI, April 21, 2026 /PRNewswire/…

3 weeks ago

Total Investment of Approx. USD 8.5 Million in Malaria and NTD R&D Projects With Partners Including MMV, GSK, Tanabe Pharma, Eisai and DNDi

TOKYO, April 22, 2026 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY…

3 weeks ago

Kyverna Presents Registrational Trial Primary Analysis for Miv-cel in Stiff Person Syndrome Demonstrating Statistically Significant, Durable Clinical Benefit Across All Endpoints in an Oral, Late-Breaker Session at AAN Annual Meeting

Single-dose of miv-cel achieved robust and durable improvements in mobility, reversed disability scores, and eliminated the need for chronic immunotherapies…

3 weeks ago

RNK Health NAD+ Longevity Therapy Claims Evaluated: The Clinician-Guided NAD Injections & Medication Protocol

Des Moines, IA, April 21, 2026 (GLOBE NEWSWIRE) -- The information below contains affiliate links. If a purchase is made…

3 weeks ago